nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Vinblastine—head and neck cancer	0.38	0.457	CbGbCtD
Eprosartan—ABCC2—Docetaxel—head and neck cancer	0.313	0.377	CbGbCtD
Eprosartan—CYP2C9—Fluorouracil—head and neck cancer	0.138	0.166	CbGbCtD
Eprosartan—Neuritis—Vinblastine—head and neck cancer	0.00473	0.0281	CcSEcCtD
Eprosartan—Bone pain—Vinblastine—head and neck cancer	0.00368	0.0219	CcSEcCtD
Eprosartan—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00292	0.0174	CcSEcCtD
Eprosartan—Herpes simplex—Fluorouracil—head and neck cancer	0.00251	0.0149	CcSEcCtD
Eprosartan—Face oedema—Hydroxyurea—head and neck cancer	0.00225	0.0134	CcSEcCtD
Eprosartan—Neuritis—Docetaxel—head and neck cancer	0.00224	0.0133	CcSEcCtD
Eprosartan—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00219	0.013	CcSEcCtD
Eprosartan—Angina pectoris—Vinblastine—head and neck cancer	0.00216	0.0128	CcSEcCtD
Eprosartan—Otitis media—Docetaxel—head and neck cancer	0.00215	0.0128	CcSEcCtD
Eprosartan—Oesophagitis—Fluorouracil—head and neck cancer	0.00212	0.0126	CcSEcCtD
Eprosartan—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00211	0.0125	CcSEcCtD
Eprosartan—Rigors—Docetaxel—head and neck cancer	0.00205	0.0122	CcSEcCtD
Eprosartan—Depression—Vinblastine—head and neck cancer	0.00197	0.0117	CcSEcCtD
Eprosartan—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00193	0.0115	CcSEcCtD
Eprosartan—Swelling—Fluorouracil—head and neck cancer	0.00191	0.0113	CcSEcCtD
Eprosartan—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00176	0.0105	CcSEcCtD
Eprosartan—Pharyngitis—Vinblastine—head and neck cancer	0.00176	0.0104	CcSEcCtD
Eprosartan—Bone pain—Docetaxel—head and neck cancer	0.00175	0.0104	CcSEcCtD
Eprosartan—Cardiac failure—Fluorouracil—head and neck cancer	0.00172	0.0102	CcSEcCtD
Eprosartan—Osteoarthritis—Fluorouracil—head and neck cancer	0.00168	0.00998	CcSEcCtD
Eprosartan—Influenza like illness—Docetaxel—head and neck cancer	0.00162	0.00964	CcSEcCtD
Eprosartan—Ataxia—Fluorouracil—head and neck cancer	0.00158	0.00939	CcSEcCtD
Eprosartan—Oesophagitis—Docetaxel—head and neck cancer	0.00153	0.00907	CcSEcCtD
Eprosartan—Muscular weakness—Fluorouracil—head and neck cancer	0.00148	0.00881	CcSEcCtD
Eprosartan—Chills—Hydroxyurea—head and neck cancer	0.00145	0.00861	CcSEcCtD
Eprosartan—Ill-defined disorder—Vinblastine—head and neck cancer	0.00143	0.0085	CcSEcCtD
Eprosartan—Angina pectoris—Fluorouracil—head and neck cancer	0.00142	0.00841	CcSEcCtD
Eprosartan—Malaise—Vinblastine—head and neck cancer	0.00139	0.00826	CcSEcCtD
Eprosartan—Vertigo—Vinblastine—head and neck cancer	0.00139	0.00823	CcSEcCtD
Eprosartan—Swelling—Docetaxel—head and neck cancer	0.00138	0.00817	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00135	0.00802	CcSEcCtD
Eprosartan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00131	0.00775	CcSEcCtD
Eprosartan—Discomfort—Vinblastine—head and neck cancer	0.0013	0.0077	CcSEcCtD
Eprosartan—Hot flush—Docetaxel—head and neck cancer	0.0013	0.0077	CcSEcCtD
Eprosartan—Menopausal symptoms—Docetaxel—head and neck cancer	0.00129	0.00764	CcSEcCtD
Eprosartan—Atrial fibrillation—Docetaxel—head and neck cancer	0.00128	0.0076	CcSEcCtD
Eprosartan—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00127	0.00754	CcSEcCtD
Eprosartan—Malaise—Hydroxyurea—head and neck cancer	0.00127	0.00753	CcSEcCtD
Eprosartan—Conjunctivitis—Fluorouracil—head and neck cancer	0.00126	0.00748	CcSEcCtD
Eprosartan—Urinary tract infection—Fluorouracil—head and neck cancer	0.00126	0.00748	CcSEcCtD
Eprosartan—Cardiac failure—Docetaxel—head and neck cancer	0.00124	0.00738	CcSEcCtD
Eprosartan—Thrombocytopenia—Vinblastine—head and neck cancer	0.00123	0.00732	CcSEcCtD
Eprosartan—Epistaxis—Fluorouracil—head and neck cancer	0.00122	0.00726	CcSEcCtD
Eprosartan—Hyponatraemia—Docetaxel—head and neck cancer	0.00122	0.00723	CcSEcCtD
Eprosartan—Sinusitis—Fluorouracil—head and neck cancer	0.00122	0.00722	CcSEcCtD
Eprosartan—Anorexia—Vinblastine—head and neck cancer	0.0012	0.00713	CcSEcCtD
Eprosartan—Migraine—Docetaxel—head and neck cancer	0.00119	0.00709	CcSEcCtD
Eprosartan—Discomfort—Hydroxyurea—head and neck cancer	0.00118	0.00703	CcSEcCtD
Eprosartan—Rhinitis—Fluorouracil—head and neck cancer	0.00117	0.00692	CcSEcCtD
Eprosartan—Pharyngitis—Fluorouracil—head and neck cancer	0.00115	0.00685	CcSEcCtD
Eprosartan—Ataxia—Docetaxel—head and neck cancer	0.00114	0.00678	CcSEcCtD
Eprosartan—Paraesthesia—Vinblastine—head and neck cancer	0.00113	0.00671	CcSEcCtD
Eprosartan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00112	0.00667	CcSEcCtD
Eprosartan—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00111	0.00658	CcSEcCtD
Eprosartan—Anorexia—Hydroxyurea—head and neck cancer	0.00109	0.0065	CcSEcCtD
Eprosartan—Decreased appetite—Vinblastine—head and neck cancer	0.00109	0.0065	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00109	0.00649	CcSEcCtD
Eprosartan—Constipation—Vinblastine—head and neck cancer	0.00108	0.00639	CcSEcCtD
Eprosartan—Pain—Vinblastine—head and neck cancer	0.00108	0.00639	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00107	0.00636	CcSEcCtD
Eprosartan—Feeling abnormal—Vinblastine—head and neck cancer	0.00104	0.00616	CcSEcCtD
Eprosartan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00103	0.00611	CcSEcCtD
Eprosartan—Dyspnoea—Hydroxyurea—head and neck cancer	0.00102	0.00608	CcSEcCtD
Eprosartan—Angina pectoris—Docetaxel—head and neck cancer	0.00102	0.00607	CcSEcCtD
Eprosartan—Somnolence—Hydroxyurea—head and neck cancer	0.00102	0.00606	CcSEcCtD
Eprosartan—Dyspepsia—Hydroxyurea—head and neck cancer	0.00101	0.006	CcSEcCtD
Eprosartan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000998	0.00593	CcSEcCtD
Eprosartan—Abdominal pain—Vinblastine—head and neck cancer	0.000995	0.00591	CcSEcCtD
Eprosartan—Fatigue—Hydroxyurea—head and neck cancer	0.00099	0.00588	CcSEcCtD
Eprosartan—Pain—Hydroxyurea—head and neck cancer	0.000982	0.00583	CcSEcCtD
Eprosartan—Constipation—Hydroxyurea—head and neck cancer	0.000982	0.00583	CcSEcCtD
Eprosartan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000946	0.00562	CcSEcCtD
Eprosartan—Hypersensitivity—Vinblastine—head and neck cancer	0.000927	0.00551	CcSEcCtD
Eprosartan—Renal failure—Docetaxel—head and neck cancer	0.000919	0.00546	CcSEcCtD
Eprosartan—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000917	0.00544	CcSEcCtD
Eprosartan—Conjunctivitis—Docetaxel—head and neck cancer	0.000909	0.0054	CcSEcCtD
Eprosartan—Body temperature increased—Hydroxyurea—head and neck cancer	0.000908	0.00539	CcSEcCtD
Eprosartan—Asthenia—Vinblastine—head and neck cancer	0.000903	0.00536	CcSEcCtD
Eprosartan—Epistaxis—Docetaxel—head and neck cancer	0.000882	0.00524	CcSEcCtD
Eprosartan—Chest pain—Fluorouracil—head and neck cancer	0.000862	0.00512	CcSEcCtD
Eprosartan—Myalgia—Fluorouracil—head and neck cancer	0.000862	0.00512	CcSEcCtD
Eprosartan—Diarrhoea—Vinblastine—head and neck cancer	0.000861	0.00511	CcSEcCtD
Eprosartan—Discomfort—Fluorouracil—head and neck cancer	0.000852	0.00506	CcSEcCtD
Eprosartan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000846	0.00502	CcSEcCtD
Eprosartan—Rhinitis—Docetaxel—head and neck cancer	0.000842	0.005	CcSEcCtD
Eprosartan—Pharyngitis—Docetaxel—head and neck cancer	0.000833	0.00495	CcSEcCtD
Eprosartan—Dizziness—Vinblastine—head and neck cancer	0.000832	0.00494	CcSEcCtD
Eprosartan—Oedema peripheral—Docetaxel—head and neck cancer	0.000827	0.00491	CcSEcCtD
Eprosartan—Asthenia—Hydroxyurea—head and neck cancer	0.000824	0.00489	CcSEcCtD
Eprosartan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000809	0.0048	CcSEcCtD
Eprosartan—Visual impairment—Docetaxel—head and neck cancer	0.000809	0.0048	CcSEcCtD
Eprosartan—Tachycardia—Fluorouracil—head and neck cancer	0.000806	0.00479	CcSEcCtD
Eprosartan—Vomiting—Vinblastine—head and neck cancer	0.0008	0.00475	CcSEcCtD
Eprosartan—Headache—Vinblastine—head and neck cancer	0.000789	0.00468	CcSEcCtD
Eprosartan—Anorexia—Fluorouracil—head and neck cancer	0.000788	0.00468	CcSEcCtD
Eprosartan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000785	0.00466	CcSEcCtD
Eprosartan—Hypotension—Fluorouracil—head and neck cancer	0.000772	0.00459	CcSEcCtD
Eprosartan—Dizziness—Hydroxyurea—head and neck cancer	0.000759	0.00451	CcSEcCtD
Eprosartan—Chills—Docetaxel—head and neck cancer	0.000753	0.00447	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000753	0.00447	CcSEcCtD
Eprosartan—Nausea—Vinblastine—head and neck cancer	0.000748	0.00444	CcSEcCtD
Eprosartan—Insomnia—Fluorouracil—head and neck cancer	0.000747	0.00444	CcSEcCtD
Eprosartan—Paraesthesia—Fluorouracil—head and neck cancer	0.000742	0.00441	CcSEcCtD
Eprosartan—Dyspnoea—Fluorouracil—head and neck cancer	0.000737	0.00437	CcSEcCtD
Eprosartan—Somnolence—Fluorouracil—head and neck cancer	0.000735	0.00436	CcSEcCtD
Eprosartan—Vomiting—Hydroxyurea—head and neck cancer	0.00073	0.00433	CcSEcCtD
Eprosartan—Dyspepsia—Fluorouracil—head and neck cancer	0.000727	0.00432	CcSEcCtD
Eprosartan—Rash—Hydroxyurea—head and neck cancer	0.000724	0.0043	CcSEcCtD
Eprosartan—Dermatitis—Hydroxyurea—head and neck cancer	0.000723	0.00429	CcSEcCtD
Eprosartan—Headache—Hydroxyurea—head and neck cancer	0.000719	0.00427	CcSEcCtD
Eprosartan—Decreased appetite—Fluorouracil—head and neck cancer	0.000718	0.00427	CcSEcCtD
Eprosartan—Back pain—Docetaxel—head and neck cancer	0.000707	0.0042	CcSEcCtD
Eprosartan—Pain—Fluorouracil—head and neck cancer	0.000707	0.0042	CcSEcCtD
Eprosartan—Muscle spasms—Docetaxel—head and neck cancer	0.000703	0.00417	CcSEcCtD
Eprosartan—Nausea—Hydroxyurea—head and neck cancer	0.000682	0.00405	CcSEcCtD
Eprosartan—Feeling abnormal—Fluorouracil—head and neck cancer	0.000681	0.00404	CcSEcCtD
Eprosartan—Urticaria—Fluorouracil—head and neck cancer	0.000656	0.0039	CcSEcCtD
Eprosartan—Syncope—Docetaxel—head and neck cancer	0.000655	0.00389	CcSEcCtD
Eprosartan—Body temperature increased—Fluorouracil—head and neck cancer	0.000653	0.00388	CcSEcCtD
Eprosartan—Palpitations—Docetaxel—head and neck cancer	0.000646	0.00383	CcSEcCtD
Eprosartan—Loss of consciousness—Docetaxel—head and neck cancer	0.000642	0.00381	CcSEcCtD
Eprosartan—Cough—Docetaxel—head and neck cancer	0.000638	0.00379	CcSEcCtD
Eprosartan—Arthralgia—Docetaxel—head and neck cancer	0.000622	0.00369	CcSEcCtD
Eprosartan—Myalgia—Docetaxel—head and neck cancer	0.000622	0.00369	CcSEcCtD
Eprosartan—Chest pain—Docetaxel—head and neck cancer	0.000622	0.00369	CcSEcCtD
Eprosartan—Hypersensitivity—Fluorouracil—head and neck cancer	0.000609	0.00362	CcSEcCtD
Eprosartan—Dry mouth—Docetaxel—head and neck cancer	0.000608	0.00361	CcSEcCtD
Eprosartan—Shock—Docetaxel—head and neck cancer	0.000587	0.00348	CcSEcCtD
Eprosartan—Pruritus—Fluorouracil—head and neck cancer	0.000585	0.00347	CcSEcCtD
Eprosartan—Thrombocytopenia—Docetaxel—head and neck cancer	0.000584	0.00347	CcSEcCtD
Eprosartan—Tachycardia—Docetaxel—head and neck cancer	0.000582	0.00346	CcSEcCtD
Eprosartan—Anorexia—Docetaxel—head and neck cancer	0.000569	0.00338	CcSEcCtD
Eprosartan—Diarrhoea—Fluorouracil—head and neck cancer	0.000565	0.00336	CcSEcCtD
Eprosartan—Hypotension—Docetaxel—head and neck cancer	0.000557	0.00331	CcSEcCtD
Eprosartan—Dizziness—Fluorouracil—head and neck cancer	0.000546	0.00324	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000543	0.00323	CcSEcCtD
Eprosartan—Insomnia—Docetaxel—head and neck cancer	0.000539	0.0032	CcSEcCtD
Eprosartan—Paraesthesia—Docetaxel—head and neck cancer	0.000536	0.00318	CcSEcCtD
Eprosartan—Dyspnoea—Docetaxel—head and neck cancer	0.000532	0.00316	CcSEcCtD
Eprosartan—Somnolence—Docetaxel—head and neck cancer	0.00053	0.00315	CcSEcCtD
Eprosartan—Vomiting—Fluorouracil—head and neck cancer	0.000525	0.00312	CcSEcCtD
Eprosartan—Dyspepsia—Docetaxel—head and neck cancer	0.000525	0.00312	CcSEcCtD
Eprosartan—Rash—Fluorouracil—head and neck cancer	0.000521	0.00309	CcSEcCtD
Eprosartan—Dermatitis—Fluorouracil—head and neck cancer	0.000521	0.00309	CcSEcCtD
Eprosartan—Decreased appetite—Docetaxel—head and neck cancer	0.000518	0.00308	CcSEcCtD
Eprosartan—Headache—Fluorouracil—head and neck cancer	0.000518	0.00307	CcSEcCtD
Eprosartan—Fatigue—Docetaxel—head and neck cancer	0.000514	0.00305	CcSEcCtD
Eprosartan—Constipation—Docetaxel—head and neck cancer	0.00051	0.00303	CcSEcCtD
Eprosartan—Pain—Docetaxel—head and neck cancer	0.00051	0.00303	CcSEcCtD
Eprosartan—Feeling abnormal—Docetaxel—head and neck cancer	0.000491	0.00292	CcSEcCtD
Eprosartan—Nausea—Fluorouracil—head and neck cancer	0.000491	0.00291	CcSEcCtD
Eprosartan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000488	0.0029	CcSEcCtD
Eprosartan—Abdominal pain—Docetaxel—head and neck cancer	0.000471	0.0028	CcSEcCtD
Eprosartan—Body temperature increased—Docetaxel—head and neck cancer	0.000471	0.0028	CcSEcCtD
Eprosartan—Hypersensitivity—Docetaxel—head and neck cancer	0.000439	0.00261	CcSEcCtD
Eprosartan—Asthenia—Docetaxel—head and neck cancer	0.000428	0.00254	CcSEcCtD
Eprosartan—Pruritus—Docetaxel—head and neck cancer	0.000422	0.00251	CcSEcCtD
Eprosartan—Diarrhoea—Docetaxel—head and neck cancer	0.000408	0.00242	CcSEcCtD
Eprosartan—Dizziness—Docetaxel—head and neck cancer	0.000394	0.00234	CcSEcCtD
Eprosartan—Vomiting—Docetaxel—head and neck cancer	0.000379	0.00225	CcSEcCtD
Eprosartan—Rash—Docetaxel—head and neck cancer	0.000376	0.00223	CcSEcCtD
Eprosartan—Dermatitis—Docetaxel—head and neck cancer	0.000376	0.00223	CcSEcCtD
Eprosartan—Headache—Docetaxel—head and neck cancer	0.000374	0.00222	CcSEcCtD
Eprosartan—Nausea—Docetaxel—head and neck cancer	0.000354	0.0021	CcSEcCtD
